Controversies in the management of low volume stage Ii nonseminomatous germ cell testicular cancer
Lange, P.H.; Fraley, E.E.
Seminars in Oncology 15(4): 324-334
1988
ISSN/ISBN: 0093-7754 PMID: 2841763 Document Number: 309976
Document emailed within 1 workday
Related Documents
Moul, J.W.; McCarthy, W.F.; Fernandez, E.B.; Sesterhenn, I.A. 1994: Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer Cancer Research 54(2): 362-364Peckham, M.J. 1979: An appraisal of the role of radiation therapy in the management of nonseminomatous germ-cell tumors of the testis in the era of effective chemotherapy Cancer Treatment Reports 63(9-10): 1653-1658
Rothman, J.; Greenberg, R.E.; Jaffe, W.I. 2008: Nonseminomatous germ cell tumor of the testis 9 years after a germ cell tumor of the pineal gland: case report and review of the literature Canadian Journal of Urology 15(3): 4122-4124
Nakai, Y.; Nagahara, A.; Uemura, M.; Takayama, H.; Nonomura, N. 2012: Treatment strategy for stage i testicular germ cell tumor Hinyokika Kiyo. Acta Urologica Japonica 58(12): 715-720
Akdaş, A.; Ilker, Y.; Kirkali, Z.; Bakkaloğlu, M. 1984: The results of the treatment of stage i and Ii nonseminomatous germinal testicular tumors Turkish Journal of Pediatrics 26(1-4): 291-296
Taylor, R.E.; Duncan, W. 1987: The management of germ-cell testicular tumours Journal of the Royal College of Surgeons of Edinburgh 32(1): 1-12
Chin, J.L. 2000: Recent developments in the management of testicular germ cell tumors Canadian Journal of Urology 7(4): 1060-1065
Ondrus, D. 1999: Use of prognostic factors of disease progression in the treatment of patients with stage i nonseminomatous testicular tumors Bratislavske Lekarske Listy 100(1): 61-65
Coffin, C.M.; Ewing, S.; Dehner, L.P. 1985: Frequency of intratubular germ cell neoplasia with invasive testicular germ cell tumors. Histologic and immunocytochemical features Archives of Pathology and Laboratory Medicine 109(6): 555-559
Cost, N.G. 2013: Testicular germ cell tumors. Current concepts and management strategies Minerva Urologica e Nefrologica 65(2): 133-155
Archontovasilis, F.; Katsaragakis, S.; Lagoudiannakis, E.E.; Tsekouras, D.; Genetzakis, M.; Markogiannakis, H.; Albanopoulos, K.; Manouras, A. 2008: Postchemotherapy resection of a metastatic retroperitoneal nonseminomatous germ cell tumor of the testes Minerva Urologica e Nefrologica 60(1): 69-70
Vugrin, D.; Cvitkovic, E.; Whitmore, W.F.; Golbey, R.B. 1979: Adjuvant chemotherapy in resected nonseminomatous germ cell tumors of testis: stages i and Ii Seminars in Oncology 6(1): 94-98
Knight, J.A.; Marrett, L.D.; Weir, H.K. 1996: Occupation and risk of germ cell testicular cancer by histologic type in Ontario Journal of Occupational and Environmental Medicine 38(9): 884-890
Sigg, C.; Hedinger, C. 1980: Testicular germ cell tumors and atypical germ cells Schweizerische Medizinische Wochenschrift 110(21): 801-806
Gold, E.J.; Bosl, G.J.; Itri, L.M. 1984: Phase Ii trial of 13-cis-retinoic acid in patients with advanced nonseminomatous germ cell tumors Cancer Treatment Reports 68(10): 1287-1288
Ondrus, D.; Hornák, M.; Matoska, J. 1993: Neo-adjuvant chemotherapy with delayed orchiectomy in patients with advanced germ cell testicular cancer Neoplasma 40(3): 189-192
Gerl, A.; Lamerz, R.; Mann, K.; Clemm, C.; Wilmanns, W. 1997: Is serum tumor marker half-life a guide to prognosis in metastatic nonseminomatous germ cell tumors? Anticancer Research 17(4b): 3047-3049
Yatsuyanagi, E.; Kusajima, K.; Suzuki, M.; Hirano, T.; Sakurada, T.; Kikuchi, Y.; Sugawara, Y. 2004: Induction chemotherapy and radical resection for primary nonseminomatous mediastinal germ cell tumor (NSGCT); report of a case Kyobu Geka. Japanese Journal of Thoracic Surgery 57(2): 168-171
Brehmer, B.; Hossfeld, D.K.; Kersting, D. 1977: Combined surgical and cytostatic therapy in patients with advanced metastatic nonseminomatous testicular cancer Der Urologe. Ausg. a 16(6): 331-333
Toner, G.C.; Geller, N.L.; Tan, C.; Nisselbaum, J.; Bosl, G.J. 1990: Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors Cancer Research 50(18): 5904-5910